Luke Nathaniel Walker, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 14,200 shares at $1.76 ($25K) on 2025-01-31, disclosed to the SEC on 2025-02-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.